McKinsey, Opioids, & Ethics
CaseInterview.com
FEBRUARY 10, 2026
A couple of weeks ago, McKinsey settled a major lawsuit regarding the firm’s work with the manufacturer of OxyContin — one of the key drugs in the opioid crisis that has claimed many lives. The settlement was for close to $600 million, as reported by the New York Times. Here are my thoughts…. First, I’m beyond disappointed in McKinsey’s role in furthering the opioid epidemic. The settlement allows McKinsey to avoid admitting legal wrongdoing. They claim their actions were legal.
Let's personalize your content